11-Oxomogroside IIe

CAS No. 918972-06-2

11-Oxomogroside IIe( ——— )

Catalog No. M38842 CAS No. 918972-06-2

11-Oxomogroside IIe is a triterpene glycoside isolated from Siraitia grosvenori.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 232 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    11-Oxomogroside IIe
  • Note
    Research use only, not for human use.
  • Brief Description
    11-Oxomogroside IIe is a triterpene glycoside isolated from Siraitia grosvenori.
  • Description
    11-Oxomogroside IIe is a triterpene glycoside isolated from Siraitia grosvenori.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    918972-06-2
  • Formula Weight
    799
  • Molecular Formula
    C42H70O14
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li D, et al. Cucurbitane glycosides from unripe fruits of Lo Han Kuo (Siraitia grosvenori). Chem Pharm Bull (Tokyo). 2006 Oct;54(10):1425-8.?
molnova catalog
related products
  • Acetyl-(D-Arg10,Cys1...

    Ac-DArg-c[Cys-Glu-His-DPhe-Arg-Trp-Cys]-NH 2 is a cyclic octapeptide with MC4R agonism. Ac-DArg-c[Cys-Glu-His-DPhe-Arg-Trp-Cys]-NH 2 significantly increases heart rate and blood pressure.

  • DL-Carnitine

    Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.

  • AKOS037652256

    AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.